Success Metrics

Clinical Success Rate
85.7%

Based on 36 completed trials

Completion Rate
86%(36/42)
Active Trials
8(11%)
Results Posted
39%(14 trials)
Terminated
6(8%)

Phase Distribution

Ph phase_1
9
13%
Ph phase_2
17
24%
Ph phase_4
19
27%
Ph early_phase_1
2
3%
Ph not_applicable
12
17%
Ph phase_3
12
17%

Phase Distribution

11

Early Stage

17

Mid Stage

31

Late Stage

Phase Distribution71 total trials
Early Phase 1First-in-human
2(2.8%)
Phase 1Safety & dosage
9(12.7%)
Phase 2Efficacy & side effects
17(23.9%)
Phase 3Large-scale testing
12(16.9%)
Phase 4Post-market surveillance
19(26.8%)
N/ANon-phased studies
12(16.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.8%

36 of 44 finished

Non-Completion Rate

18.2%

8 ended early

Currently Active

8

trials recruiting

Total Trials

71

all time

Status Distribution
Active(14)
Completed(36)
Terminated(8)
Other(13)

Detailed Status

Completed36
unknown13
Recruiting7
Not yet recruiting6
Terminated6
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
71
Active
8
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (2.8%)
Phase 19 (12.7%)
Phase 217 (23.9%)
Phase 312 (16.9%)
Phase 419 (26.8%)
N/A12 (16.9%)

Trials by Status

completed3651%
not_yet_recruiting68%
active_not_recruiting11%
recruiting710%
terminated68%
unknown1318%
withdrawn23%

Recent Activity

Clinical Trials (71)

Showing 20 of 71 trialsScroll for more
NCT07855523Phase 4

Efficacy of Intravenous Midazolam-Ketamine Combination Versus Placebo for Prevention of Post-Spinal Shivering in Elective Cesarean Section

Not Yet Recruiting
NCT02233985Phase 4

Nebulized 3% Hypertonic Saline Solution Treatment of Bronchiolitis in Infants

Completed
NCT07353307Phase 3

A Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetic Profile of TRD303 for Postoperative Analgesia After Abdominal Surgery in China.

Completed
NCT07841054Not Applicable

Renoprotective Effects of Dexmedetomidine Preconditioning in CABG Surgery

Completed
NCT06303570Phase 2

A Study to Evaluate the Efficacy and Safety of CBL-514 Compared to Placebo in Participants With Dercum's Disease Lipomas

Completed
NCT07140939Phase 3

A Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat

Recruiting
NCT07816848Not Applicable

Intravenous Magnesium Sulfate for Post-Endoscopic Symptoms After Upper Gastrointestinal Endoscopy With Biopsy

Completed
NCT07612839Not Applicable

Intravenous Lidocaine for Postoperative Fatigue After Laparoscopic TAPP Inguinal Hernia Repair

Not Yet Recruiting
NCT07490808Not Applicable

Peri-procedural Hydration to Prevent Acute Kidney Injury After Pulsed Field Ablation for Atrial Fibrillation

Active Not Recruiting
NCT07077746Phase 2

HB-adMSCs for the Treatment of Crohn's Disease

Recruiting
NCT03772990Phase 4

Calcium Administration in Cardiac Surgery

Completed
NCT07733947Phase 3

A Study to Evaluate the Maintenance of Efficacy and Long-term Safety of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 1)

Not Yet Recruiting
NCT07519109Phase 1

Study Evaluating the Safety, Efficacy and Pharmacokinetics of SYH9089 Injection in Patients Undergoing Abdominal Surgery.

Recruiting
NCT07620327Phase 4

Effect of Push-Dose Adrenaline on Peri-intubation Hypotension During Rapid Sequence Intubation in the Emergency Department

Not Yet Recruiting
NCT07608770Phase 2

A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat

Recruiting
NCT07318155Phase 2

A Study of SRSD107 in Participants With Chronic Coronary and/or Peripheral Arterial Disease

Recruiting
NCT07526974Phase 3

A Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat ( SUPREME-02 )

Not Yet Recruiting
NCT07437339Phase 4

Volume Reduction for Open Fracture Irrigation

Recruiting
NCT07240987Phase 1

Mesenchymal Stem Cells for Chronic Kidney Diseases

Not Yet Recruiting
NCT05752279Phase 3

Balanced Multi-Electrolyte Solution Versus Saline Trial for Diabetic KetoAcidosis

Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
71